Literature DB >> 35101413

Understanding the role of sex hormones in cancer for the transgender community.

Sarah S Jackson1, Kate Z Nambiar2, Stewart O'Callaghan3, Alison May Berner4.   

Abstract

Sex hormones are crucial for the body's development and function. Therefore, many transgender people seek hormone therapy as part of their transition. However, sex hormones modulate cancer risk. Studying sex hormones in cisgender and transgender populations will improve our knowledge of their biological role in cancer and reduce health disparities.
Copyright © 2022. Published by Elsevier Inc.

Entities:  

Keywords:  cancer risk; oestrogen; sex hormones; sex steroids; testosterone; transgender

Mesh:

Substances:

Year:  2022        PMID: 35101413      PMCID: PMC8930500          DOI: 10.1016/j.trecan.2022.01.005

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  14 in total

Review 1.  Cancer Risk in Transgender People.

Authors:  Christel J M de Blok; Koen M A Dreijerink; Martin den Heijer
Journal:  Endocrinol Metab Clin North Am       Date:  2019-03-23       Impact factor: 4.741

Review 2.  Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review.

Authors:  Harsh Patel; Victor Arruarana; Lucille Yao; Xiaojiang Cui; Edward Ray
Journal:  Endocrine       Date:  2020-02-17       Impact factor: 3.633

Review 3.  Endocrinology of Transgender Medicine.

Authors:  Guy T'Sjoen; Jon Arcelus; Louis Gooren; Daniel T Klink; Vin Tangpricha
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

4.  Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank.

Authors:  Sandar Tin Tin; Gillian K Reeves; Timothy J Key
Journal:  Br J Cancer       Date:  2021-04-16       Impact factor: 7.640

Review 5.  Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review.

Authors:  Holly R Harris; Kathryn L Terry
Journal:  Fertil Res Pract       Date:  2016-12-05

6.  Inclusion of transgender and gender diverse health data in cancer biorepositories.

Authors:  Nat C Jones; Amy K Otto; Dana E Ketcher; Jennifer B Permuth; Gwendolyn P Quinn; Matthew B Schabath
Journal:  Contemp Clin Trials Commun       Date:  2020-06-16

7.  Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.

Authors:  Christel J M de Blok; Chantal M Wiepjes; Nienke M Nota; Klaartje van Engelen; Muriel A Adank; Koen M A Dreijerink; Ellis Barbé; Inge R H M Konings; Martin den Heijer
Journal:  BMJ       Date:  2019-05-14

8.  Cancer Stage, Treatment, and Survival Among Transgender Patients in the United States.

Authors:  Sarah S Jackson; Xuesong Han; Ziling Mao; Leticia Nogueira; Gita Suneja; Ahmedin Jemal; Meredith S Shiels
Journal:  J Natl Cancer Inst       Date:  2021-09-04       Impact factor: 11.816

Review 9.  Estrogen receptor beta in prostate cancer: friend or foe?

Authors:  Adam W Nelson; Wayne D Tilley; David E Neal; Jason S Carroll
Journal:  Endocr Relat Cancer       Date:  2014-01-08       Impact factor: 5.678

10.  Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies.

Authors:  Eleanor L Watts; Paul N Appleby; Aurora Perez-Cornago; H Bas Bueno-de-Mesquita; June M Chan; Chu Chen; Barbara A Cohn; Michael B Cook; Leon Flicker; Neal D Freedman; Graham G Giles; Edward Giovannucci; Randi E Gislefoss; Graeme J Hankey; Rudolf Kaaks; Paul Knekt; Laurence N Kolonel; Tatsuhiko Kubo; Loïc Le Marchand; Robert N Luben; Tapio Luostarinen; Satu Männistö; E Jeffrey Metter; Kazuya Mikami; Roger L Milne; Kotaro Ozasa; Elizabeth A Platz; J Ramón Quirós; Harri Rissanen; Norie Sawada; Meir Stampfer; Frank Z Stanczyk; Pär Stattin; Akiko Tamakoshi; Catherine M Tangen; Ian M Thompson; Konstantinos K Tsilidis; Shoichiro Tsugane; Giske Ursin; Lars Vatten; Noel S Weiss; Bu B Yeap; Naomi E Allen; Timothy J Key; Ruth C Travis
Journal:  Eur Urol       Date:  2018-08-01       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.